Vascular Solutions, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Postpones proposed $40 mil. initial public offering, citing "turbulent" market conditions. A re-evaluation is planned in January. The Minneapolis maker of the Duett vascular sealing device filed a preliminary prospectus for the offering in July with the Securities and Exchange Commission (1"The Gray Sheet" Aug. 9, p. 14)
You may also be interested in...
Vascular Solutions Preparing For Duett Vascular Sealing Launch, Going Public
Vascular Solutions says it will allocate roughly $12 mil. of its upcoming $40 mil. initial public offering to establish a direct U.S. sales force over the next year to market the Duett vascular sealing device, which currently awaits FDA approval.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.